FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
This photo provided by Vertex Pharmaceuticals in January 2025 shows a tablet and bottle of the JOURNAVX (suzetrigine) medication. (Vertex Pharmaceuticals via AP)(Vertex Pharmaceuticals via AP) WASHINGTON (AP) — Federal…